Lytic bacteriophages and probiotic Bacillus spp. as novel biocontrol agents of Motile Aeromonad Septicaemia (MAS) in farmed Nile tilapia (Oreochromis niloticus): A holistic approach to disease management.

01 October 2022 → 30 September 2027
Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Virology
    • Microbiology not elsewhere classified
Bacteriophages Probiotics Bacillus spp. Aeromonas hydrophila Antibiotics Aquaculture Nile tilapia
Project description

Local bacteriophages and probiotic Bacillus spp. will be isolated and characterized. The isolates wil be tested against Aeromonas hydrophila, both in vivo and in vitro under lab conditions. Bacillus spp. will be combined together with selected bacteriophages to test for a synergistic effect under lab conditions. Semi-field trials will conducted on Nile tilapia (Oreochromis niloticus) for field verification.